Data as of Nov 21
| +0.42 / +2.00%|
The 8 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 24.50, with a high estimate of 107.00 and a low estimate of 14.00. The median estimate represents a +14.65% increase from the last price of 21.37.
The current consensus among 9 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.